10 20 30 40 50 60 70 80 2XQW - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER IMMUNE SYSTEM 07-SEP-10 2XQW
TITLE STRUCTURE OF FACTOR H DOMAINS 19-20 IN COMPLEX WITH COMPLEMENT C3D
COMPND MOL_ID: 1; COMPND 2 MOLECULE: COMPLEMENT C3; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: THIOESTER DOMAIN, RESIDUES 996-1287; COMPND 5 SYNONYM: C3 AND PZP-LIKE ALPHA-2-MACROGLOBULIN DOMAIN-CONTAINING COMPND 6 PROTEIN 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: COMPLEMENT FACTOR H; COMPND 11 CHAIN: C; COMPND 12 FRAGMENT: DOMAINS 19-20, RESIDUES 1103-1231; COMPND 13 SYNONYM: H FACTOR 1; COMPND 14 ENGINEERED: YES; COMPND 15 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET15; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 4922
KEYWDS IMMUNE SYSTEM, COMPLEMENT ALTERNATIVE PATHWAY, ATYPICAL HEMOLYTIC KEYWDS 2 UREMIC SYNDROME, AHUS, CFH, FH, C3B
EXPDTA X-RAY DIFFRACTION
AUTHOR T.KAJANDER,M.J.LEHTINEN,S.HYVARINEN,A.BHATTACHARJEE,E.LEUNG, AUTHOR 2 D.E.ISENMAN,S.MERI,T.S.JOKIRANTA,A.GOLDMAN
REVDAT 3 17-AUG-11 2XQW 1 JRNL REMARK VERSN REVDAT 2 16-FEB-11 2XQW 1 JRNL REMARK MASTER REVDAT 1 02-FEB-11 2XQW 0
JRNL AUTH T.KAJANDER,M.J.LEHTINEN,S.HYVARINEN,A.BHATTACHARJEE,E.LEUNG, JRNL AUTH 2 D.E.ISENMAN,S.MERI,A.GOLDMAN,T.S.JOKIRANTA JRNL TITL DUAL INTERACTION OF FACTOR H WITH C3D AND JRNL TITL 2 GLYCOSAMINOGLYCANS IN HOST-NONHOST DISCRIMINATION BY JRNL TITL 3 COMPLEMENT. JRNL REF PROC.NATL.ACAD.SCI.USA V. 108 2897 2011 JRNL REFN ISSN 0027-8424 JRNL PMID 21285368 JRNL DOI 10.1073/PNAS.1017087108
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.S.JOKIRANTA,V.JAAKOLA,M.J.LEHTINEN,M.PAREPALO,S.MERI, REMARK 1 AUTH 2 A.GOLDMAN REMARK 1 TITL STRUCTURE OF COMPLEMENT FACTOR H CARBOXYL-TERMINUS REVEALS REMARK 1 TITL 2 MOLECULAR BASIS OF ATYPICAL HAEMOLYTIC UREMIC SYNDROME. REMARK 1 REF EMBO J. V. 25 1784 2006 REMARK 1 REFN ISSN 0261-4189 REMARK 1 PMID 16601698 REMARK 1 DOI 10.1038/SJ.EMBOJ.7601052 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.J.LEHTINEN,A.L.ROPS,D.E.ISENMAN,J.VAN DER VLAG, REMARK 1 AUTH 2 T.S.JOKIRANTA REMARK 1 TITL MUTATIONS OF FACTOR H IMPAIR REGULATION OF SURFACE- BOUND REMARK 1 TITL 2 C3B BY THREE MECHANISMS IN ATYPICAL HEMOLYTIC UREMIC REMARK 1 TITL 3 SYNDROME. REMARK 1 REF J.BIOL.CHEM. V. 284 15650 2009 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 19351878 REMARK 1 DOI 10.1074/JBC.M900814200
REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.306 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.753 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.39 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.41 REMARK 3 NUMBER OF REFLECTIONS : 36767 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.2026 REMARK 3 R VALUE (WORKING SET) : 0.2005 REMARK 3 FREE R VALUE : 0.2420 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 3723 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.7602 - 6.9065 0.98 2575 138 0.1525 0.1739 REMARK 3 2 6.9065 - 5.4858 1.00 2624 141 0.1773 0.2054 REMARK 3 3 5.4858 - 4.7935 1.00 2642 141 0.1632 0.2274 REMARK 3 4 4.7935 - 4.3557 1.00 2624 136 0.1570 0.2122 REMARK 3 5 4.3557 - 4.0438 1.00 2646 141 0.1724 0.2017 REMARK 3 6 4.0438 - 3.8056 1.00 2549 134 0.1770 0.2567 REMARK 3 7 3.8056 - 3.6151 1.00 2687 140 0.1901 0.1955 REMARK 3 8 3.6151 - 3.4578 1.00 2609 139 0.1913 0.2403 REMARK 3 9 3.4578 - 3.3247 1.00 2644 140 0.2181 0.2219 REMARK 3 10 3.3247 - 3.2101 1.00 2596 136 0.2078 0.2922 REMARK 3 11 3.2101 - 3.1097 1.00 2662 141 0.2145 0.2664 REMARK 3 12 3.1097 - 3.0209 1.00 2592 137 0.2151 0.2769 REMARK 3 13 3.0209 - 2.9414 1.00 2658 139 0.2113 0.2077 REMARK 3 14 2.9414 - 2.8696 1.00 2612 140 0.2249 0.2638 REMARK 3 15 2.8696 - 2.8044 1.00 2618 138 0.2282 0.3192 REMARK 3 16 2.8044 - 2.7447 1.00 2655 140 0.2384 0.2578 REMARK 3 17 2.7447 - 2.6898 1.00 2582 138 0.2408 0.3225 REMARK 3 18 2.6898 - 2.6391 1.00 2630 140 0.2561 0.2878 REMARK 3 19 2.6391 - 2.5919 1.00 2586 136 0.2399 0.2773 REMARK 3 20 2.5919 - 2.5480 1.00 2674 140 0.2382 0.2562 REMARK 3 21 2.5480 - 2.5069 1.00 2591 137 0.2484 0.2903 REMARK 3 22 2.5069 - 2.4684 1.00 2596 137 0.2514 0.2948 REMARK 3 23 2.4684 - 2.4321 1.00 2657 139 0.2646 0.3339 REMARK 3 24 2.4321 - 2.3978 1.00 2603 136 0.2759 0.3372 REMARK 3 25 2.3978 - 2.3654 1.00 2634 137 0.2879 0.2983 REMARK 3 26 2.3654 - 2.3347 1.00 2594 138 0.2941 0.3558 REMARK 3 27 2.3347 - 2.3055 0.90 2347 124 0.3089 0.3398 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.331 REMARK 3 B_SOL : 52.214 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.38 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.00 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.65 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.18 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.7952 REMARK 3 B22 (A**2) : 5.7952 REMARK 3 B33 (A**2) : -11.5904 REMARK 3 B12 (A**2) : 0.0000 REMARK 3 B13 (A**2) : 0.0000 REMARK 3 B23 (A**2) : 0.0000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 5634 REMARK 3 ANGLE : 0.960 7643 REMARK 3 CHIRALITY : 0.067 852 REMARK 3 PLANARITY : 0.005 985 REMARK 3 DIHEDRAL : 18.570 2008 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2XQW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-SEP-10. REMARK 100 THE PDBE ID CODE IS EBI-45307.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUN-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.983 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD (QUANTUM 315R) REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37791 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.30 REMARK 200 RESOLUTION RANGE LOW (A) : 50.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.6 REMARK 200 R MERGE (I) : 0.07 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.30 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 5.6 REMARK 200 R MERGE FOR SHELL (I) : 0.75 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.36 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1C3D REMARK 200 REMARK 200 REMARK: NONE
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12-18% PEG 4000, 0.1 M HEPES, REMARK 280 PH 7.5, AT 22 DEGREES C
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.07033 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 94.14067 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 70.60550 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 117.67583 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 23.53517 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2230 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 35440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS1010 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, CYS1010 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN C, ASP1119 TO GLY REMARK 400 ENGINEERED RESIDUE IN CHAIN C, GLN1139 TO ALA
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA C 1099 REMARK 465 GLY C 1100 REMARK 465 ILE C 1101 REMARK 465 GLN C 1102 REMARK 465 LYS C 1103 REMARK 465 ASP C 1104 REMARK 465 SER C 1105 REMARK 465 THR C 1106 REMARK 465 GLY C 1107 REMARK 465 LYS C 1108
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 8 CG CD CE NZ REMARK 470 GLU A 42 CG CD OE1 OE2 REMARK 470 LYS A 43 CG CD CE NZ REMARK 470 ASN A 143 CG OD1 ND2 REMARK 470 LYS A 222 CG CD CE NZ REMARK 470 LYS A 224 CG CD CE NZ REMARK 470 LYS A 251 CG CD CE NZ REMARK 470 ARG B 6 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 224 CG CD CE NZ REMARK 470 GLN B 233 CG CD OE1 NE2 REMARK 470 ASP B 254 CG OD1 OD2 REMARK 470 ARG B 261 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 290 CG CD OE1 NE2 REMARK 470 PHE C1123 CG CD1 CD2 CE1 CE2 CZ REMARK 470 VAL C1134 CG1 CG2 REMARK 470 GLU C1135 CG CD OE1 OE2 REMARK 470 ASN C1147 CG OD1 ND2 REMARK 470 LYS C1148 CG CD CE NZ REMARK 470 ARG C1149 CG CD NE CZ NH1 NH2 REMARK 470 ILE C1150 CG1 CG2 CD1 REMARK 470 ARG C1153 CG CD NE CZ NH1 NH2 REMARK 470 ASN C1154 CG OD1 ND2 REMARK 470 GLN C1187 OE1 NE2 REMARK 470 ARG C1206 CG CD NE CZ NH1 NH2 REMARK 470 ARG C1210 CG CD NE CZ NH1 NH2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 17 -155.56 -85.41 REMARK 500 SER A 71 5.60 87.52 REMARK 500 ASN A 142 102.64 -49.55 REMARK 500 ASN A 144 142.16 -170.10 REMARK 500 ASP A 223 13.13 58.31 REMARK 500 LYS A 251 15.64 56.40 REMARK 500 ASP A 252 58.86 -69.11 REMARK 500 ASP A 292 59.09 -101.78 REMARK 500 LEU B 2 108.04 -48.82 REMARK 500 ASP B 3 123.25 -36.85 REMARK 500 SER B 71 6.44 85.74 REMARK 500 ALA B 129 74.35 -159.09 REMARK 500 ASN B 142 104.51 -59.93 REMARK 500 LYS B 224 27.80 46.11 REMARK 500 ASP B 292 66.04 -112.84 REMARK 500 TYR C1128 -53.88 -123.76 REMARK 500 ALA C1129 118.33 -29.73 REMARK 500 PRO C1130 -159.13 -137.30 REMARK 500 ALA C1131 -16.95 69.43 REMARK 500 LEU C1141 -3.84 80.85 REMARK 500 THR C1184 23.40 -58.51 REMARK 500 ALA C1185 89.31 -39.14 REMARK 500 LYS C1186 -171.25 57.74 REMARK 500 GLN C1187 -64.13 89.52 REMARK 500 SER C1208 142.61 81.91 REMARK 500 LYS C1230 117.74 103.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TRP C 1183 THR C 1184 -140.47 REMARK 500 REMARK 500 REMARK: NULL
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1FHC RELATED DB: PDB REMARK 900 C3D AND HEPARIN BINDING COMPLEMENT FACTOR H DOMAINS REMARK 900 SCR19-20 REMARK 900 RELATED ID: 2JGW RELATED DB: PDB REMARK 900 STRUCTURE OF CCP MODULE 7 OF COMPLEMENT FACTOR H - REMARK 900 THE AMD AT RISK VARIENT (402H) REMARK 900 RELATED ID: 2WII RELATED DB: PDB REMARK 900 COMPLEMENT C3B IN COMPLEX WITH FACTOR H DOMAINS 1-4 REMARK 900 RELATED ID: 1KOV RELATED DB: PDB REMARK 900 HOMOLOGY MODEL OF HUMAN FACTOR H SCRS 6 AND 7 REMARK 900 RELATED ID: 2XWB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH REMARK 900 FACTORS B AND D REMARK 900 RELATED ID: 1HCC RELATED DB: PDB REMARK 900 RELATED ID: 2W81 RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN NEISSERIA MENINGITIDIS REMARK 900 FACTOR H BINDING PROTEIN AND CCPS 6-7 OF HUMAN REMARK 900 COMPLEMENT FACTOR H REMARK 900 RELATED ID: 2A74 RELATED DB: PDB REMARK 900 HUMAN COMPLEMENT COMPONENT C3C REMARK 900 RELATED ID: 1GHQ RELATED DB: PDB REMARK 900 CR2-C3D COMPLEX STRUCTURE REMARK 900 RELATED ID: 2V8E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN COMPLEMENT FACTOR H, SCR REMARK 900 DOMAINS 6-8 (H402 RISK VARIANT), IN COMPLEX WITH REMARK 900 LIGAND. REMARK 900 RELATED ID: 2W80 RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN NEISSERIA MENINGITIDIS REMARK 900 FACTOR H BINDING PROTEIN AND CCPS 6-7 OF HUMAN REMARK 900 COMPLEMENT FACTOR H REMARK 900 RELATED ID: 2HR0 RELATED DB: PDB REMARK 900 STRUCTURE OF COMPLEMENT C3B: INSIGHTS INTO REMARK 900 COMPLEMENTACTIVATION AND REGULATION REMARK 900 RELATED ID: 2WIN RELATED DB: PDB REMARK 900 C3 CONVERTASE (C3BBB) STABILIZED BY SCIN REMARK 900 RELATED ID: 2JGX RELATED DB: PDB REMARK 900 STRUCTURE OF CCP MODULE 7 OF COMPLEMENT FACTOR H - REMARK 900 THE AMD NOT AT RISK VARIENT (402Y) REMARK 900 RELATED ID: 2A73 RELATED DB: PDB REMARK 900 HUMAN COMPLEMENT COMPONENT C3 REMARK 900 RELATED ID: 2WY7 RELATED DB: PDB REMARK 900 STAPHYLOCOCCUS AUREUS COMPLEMENT SUBVERSION PROTEIN SBI-IV REMARK 900 IN COMPLEX WITH COMPLEMENT FRAGMENT C3D REVEALING AN REMARK 900 ALTERNATIVE BINDING MODE REMARK 900 RELATED ID: 1HFI RELATED DB: PDB REMARK 900 FACTOR H, 15TH C-MODULE PAIR (NMR, MINIMIZED AVERAGED REMARK 900 STRUCTURE) REMARK 900 RELATED ID: 1W2S RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF CR2 SCR 1-2 IN ITS COMPLEX REMARK 900 WITH C3D BY X-RAY SCATTERING REMARK 900 RELATED ID: 2UWN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN COMPLEMENT FACTOR H, SCR REMARK 900 DOMAINS 6-8 (H402 RISK VARIANT), IN COMPLEX WITH REMARK 900 LIGAND. REMARK 900 RELATED ID: 1C3D RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF C3D: A C3 FRAGMENT AND REMARK 900 LIGAND FOR COMPLEMENT RECEPTOR 2 REMARK 900 RELATED ID: 1HAQ RELATED DB: PDB REMARK 900 FOUR MODELS OF HUMAN FACTOR H DETERMINED BY SOLUTION REMARK 900 SCATTERING CURVE-FITTING AND HOMOLOGY MODELLING REMARK 900 RELATED ID: 2XWJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH REMARK 900 FACTOR B REMARK 900 RELATED ID: 2G7I RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN COMPLEMENT FACTOR H CARBOXYL REMARK 900 TERMINALDOMAINS 19-20: A BASIS FOR ATYPICAL HEMOLYTIC REMARK 900 UREMICSYNDROME REMARK 900 RELATED ID: 1HFH RELATED DB: PDB REMARK 900 FACTOR H, 15TH AND 16TH C-MODULE PAIR (NMR, REMARK 900 MINIMIZED AVERAGED STRUCTURE) REMARK 900 RELATED ID: 2WY8 RELATED DB: PDB REMARK 900 STAPHYLOCOCCUS AUREUS COMPLEMENT SUBVERSION PROTEIN SBI-IV REMARK 900 IN COMPLEX WITH COMPLEMENT FRAGMENT C3D
REMARK 999 REMARK 999 SEQUENCE REMARK 999 CHAIN A AND B HAVE A POINT MUTATION C17A AND FRAGMENT REMARK 999 CRYSTALLIZED HAS RESIDUES N-TERMINAL FROM CD3 GIVEN IN REMARK 999 UNP P01024 (RESIDUES 1002-1303). REMARK 999 CHAIN C FIRST FOUR RESIDUES COME FROM THE EXPRESSION VECTOR, REMARK 999 AND HAS MUTATIONS D1119G, Q1139A.
DBREF 2XQW A 3 294 UNP P01024 CO3_HUMAN 996 1287 DBREF 2XQW B 3 294 UNP P01024 CO3_HUMAN 996 1287 DBREF 2XQW C 1103 1231 UNP P08603 CFAH_HUMAN 1103 1231
SEQADV 2XQW MET A 1 UNP P01024 EXPRESSION TAG SEQADV 2XQW LEU A 2 UNP P01024 EXPRESSION TAG SEQADV 2XQW ALA A 17 UNP P01024 CYS 1010 ENGINEERED MUTATION SEQADV 2XQW MET B 1 UNP P01024 EXPRESSION TAG SEQADV 2XQW LEU B 2 UNP P01024 EXPRESSION TAG SEQADV 2XQW ALA B 17 UNP P01024 CYS 1010 ENGINEERED MUTATION SEQADV 2XQW ALA C 1099 UNP P08603 EXPRESSION TAG SEQADV 2XQW GLY C 1100 UNP P08603 EXPRESSION TAG SEQADV 2XQW ILE C 1101 UNP P08603 EXPRESSION TAG SEQADV 2XQW GLN C 1102 UNP P08603 EXPRESSION TAG SEQADV 2XQW GLY C 1119 UNP P08603 ASP 1119 ENGINEERED MUTATION SEQADV 2XQW ALA C 1139 UNP P08603 GLN 1139 ENGINEERED MUTATION
SEQRES 1 A 294 MET LEU ASP ALA GLU ARG LEU LYS HIS LEU ILE VAL THR SEQRES 2 A 294 PRO SER GLY ALA GLY GLU GLN ASN MET ILE GLY MET THR SEQRES 3 A 294 PRO THR VAL ILE ALA VAL HIS TYR LEU ASP GLU THR GLU SEQRES 4 A 294 GLN TRP GLU LYS PHE GLY LEU GLU LYS ARG GLN GLY ALA SEQRES 5 A 294 LEU GLU LEU ILE LYS LYS GLY TYR THR GLN GLN LEU ALA SEQRES 6 A 294 PHE ARG GLN PRO SER SER ALA PHE ALA ALA PHE VAL LYS SEQRES 7 A 294 ARG ALA PRO SER THR TRP LEU THR ALA TYR VAL VAL LYS SEQRES 8 A 294 VAL PHE SER LEU ALA VAL ASN LEU ILE ALA ILE ASP SER SEQRES 9 A 294 GLN VAL LEU CYS GLY ALA VAL LYS TRP LEU ILE LEU GLU SEQRES 10 A 294 LYS GLN LYS PRO ASP GLY VAL PHE GLN GLU ASP ALA PRO SEQRES 11 A 294 VAL ILE HIS GLN GLU MET ILE GLY GLY LEU ARG ASN ASN SEQRES 12 A 294 ASN GLU LYS ASP MET ALA LEU THR ALA PHE VAL LEU ILE SEQRES 13 A 294 SER LEU GLN GLU ALA LYS ASP ILE CYS GLU GLU GLN VAL SEQRES 14 A 294 ASN SER LEU PRO GLY SER ILE THR LYS ALA GLY ASP PHE SEQRES 15 A 294 LEU GLU ALA ASN TYR MET ASN LEU GLN ARG SER TYR THR SEQRES 16 A 294 VAL ALA ILE ALA GLY TYR ALA LEU ALA GLN MET GLY ARG SEQRES 17 A 294 LEU LYS GLY PRO LEU LEU ASN LYS PHE LEU THR THR ALA SEQRES 18 A 294 LYS ASP LYS ASN ARG TRP GLU ASP PRO GLY LYS GLN LEU SEQRES 19 A 294 TYR ASN VAL GLU ALA THR SER TYR ALA LEU LEU ALA LEU SEQRES 20 A 294 LEU GLN LEU LYS ASP PHE ASP PHE VAL PRO PRO VAL VAL SEQRES 21 A 294 ARG TRP LEU ASN GLU GLN ARG TYR TYR GLY GLY GLY TYR SEQRES 22 A 294 GLY SER THR GLN ALA THR PHE MET VAL PHE GLN ALA LEU SEQRES 23 A 294 ALA GLN TYR GLN LYS ASP ALA PRO SEQRES 1 B 294 MET LEU ASP ALA GLU ARG LEU LYS HIS LEU ILE VAL THR SEQRES 2 B 294 PRO SER GLY ALA GLY GLU GLN ASN MET ILE GLY MET THR SEQRES 3 B 294 PRO THR VAL ILE ALA VAL HIS TYR LEU ASP GLU THR GLU SEQRES 4 B 294 GLN TRP GLU LYS PHE GLY LEU GLU LYS ARG GLN GLY ALA SEQRES 5 B 294 LEU GLU LEU ILE LYS LYS GLY TYR THR GLN GLN LEU ALA SEQRES 6 B 294 PHE ARG GLN PRO SER SER ALA PHE ALA ALA PHE VAL LYS SEQRES 7 B 294 ARG ALA PRO SER THR TRP LEU THR ALA TYR VAL VAL LYS SEQRES 8 B 294 VAL PHE SER LEU ALA VAL ASN LEU ILE ALA ILE ASP SER SEQRES 9 B 294 GLN VAL LEU CYS GLY ALA VAL LYS TRP LEU ILE LEU GLU SEQRES 10 B 294 LYS GLN LYS PRO ASP GLY VAL PHE GLN GLU ASP ALA PRO SEQRES 11 B 294 VAL ILE HIS GLN GLU MET ILE GLY GLY LEU ARG ASN ASN SEQRES 12 B 294 ASN GLU LYS ASP MET ALA LEU THR ALA PHE VAL LEU ILE SEQRES 13 B 294 SER LEU GLN GLU ALA LYS ASP ILE CYS GLU GLU GLN VAL SEQRES 14 B 294 ASN SER LEU PRO GLY SER ILE THR LYS ALA GLY ASP PHE SEQRES 15 B 294 LEU GLU ALA ASN TYR MET ASN LEU GLN ARG SER TYR THR SEQRES 16 B 294 VAL ALA ILE ALA GLY TYR ALA LEU ALA GLN MET GLY ARG SEQRES 17 B 294 LEU LYS GLY PRO LEU LEU ASN LYS PHE LEU THR THR ALA SEQRES 18 B 294 LYS ASP LYS ASN ARG TRP GLU ASP PRO GLY LYS GLN LEU SEQRES 19 B 294 TYR ASN VAL GLU ALA THR SER TYR ALA LEU LEU ALA LEU SEQRES 20 B 294 LEU GLN LEU LYS ASP PHE ASP PHE VAL PRO PRO VAL VAL SEQRES 21 B 294 ARG TRP LEU ASN GLU GLN ARG TYR TYR GLY GLY GLY TYR SEQRES 22 B 294 GLY SER THR GLN ALA THR PHE MET VAL PHE GLN ALA LEU SEQRES 23 B 294 ALA GLN TYR GLN LYS ASP ALA PRO SEQRES 1 C 133 ALA GLY ILE GLN LYS ASP SER THR GLY LYS CYS GLY PRO SEQRES 2 C 133 PRO PRO PRO ILE ASP ASN GLY GLY ILE THR SER PHE PRO SEQRES 3 C 133 LEU SER VAL TYR ALA PRO ALA SER SER VAL GLU TYR GLN SEQRES 4 C 133 CYS ALA ASN LEU TYR GLN LEU GLU GLY ASN LYS ARG ILE SEQRES 5 C 133 THR CYS ARG ASN GLY GLN TRP SER GLU PRO PRO LYS CYS SEQRES 6 C 133 LEU HIS PRO CYS VAL ILE SER ARG GLU ILE MET GLU ASN SEQRES 7 C 133 TYR ASN ILE ALA LEU ARG TRP THR ALA LYS GLN LYS LEU SEQRES 8 C 133 TYR SER ARG THR GLY GLU SER VAL GLU PHE VAL CYS LYS SEQRES 9 C 133 ARG GLY TYR ARG LEU SER SER ARG SER HIS THR LEU ARG SEQRES 10 C 133 THR THR CYS TRP ASP GLY LYS LEU GLU TYR PRO THR CYS SEQRES 11 C 133 ALA LYS ARG
FORMUL 4 HOH *193(H2 O)
HELIX 1 1 ASP A 3 ILE A 11 5 9 HELIX 2 2 GLU A 19 GLU A 39 1 21 HELIX 3 3 GLN A 40 GLY A 45 1 6 HELIX 4 4 LEU A 46 LEU A 64 1 19 HELIX 5 5 SER A 82 VAL A 97 1 16 HELIX 6 6 ASP A 103 LYS A 118 1 16 HELIX 7 7 ILE A 137 ARG A 141 5 5 HELIX 8 8 GLU A 145 ALA A 161 1 17 HELIX 9 9 ALA A 161 GLU A 166 1 6 HELIX 10 10 SER A 171 TYR A 187 1 17 HELIX 11 11 ARG A 192 GLY A 207 1 16 HELIX 12 12 GLY A 211 THR A 219 1 9 HELIX 13 13 ASP A 223 ASN A 225 5 3 HELIX 14 14 LYS A 232 LEU A 250 1 19 HELIX 15 15 PHE A 255 GLN A 266 1 12 HELIX 16 16 SER A 275 ASP A 292 1 18 HELIX 17 17 ASP B 3 ILE B 11 5 9 HELIX 18 18 GLU B 19 THR B 38 1 20 HELIX 19 19 GLN B 40 GLY B 45 1 6 HELIX 20 20 GLU B 47 LEU B 64 1 18 HELIX 21 21 SER B 82 LEU B 95 1 14 HELIX 22 22 ASP B 103 GLN B 119 1 17 HELIX 23 23 HIS B 133 ASN B 142 5 10 HELIX 24 24 GLU B 145 GLU B 166 1 22 HELIX 25 25 SER B 171 MET B 188 1 18 HELIX 26 26 ARG B 192 MET B 206 1 15 HELIX 27 27 LYS B 210 ALA B 221 1 12 HELIX 28 28 ASP B 223 ASN B 225 5 3 HELIX 29 29 LYS B 232 LEU B 250 1 19 HELIX 30 30 PHE B 255 GLN B 266 1 12 HELIX 31 31 SER B 275 ASP B 292 1 18 HELIX 32 32 ARG C 1171 TYR C 1177 1 7
SHEET 1 CA 4 GLY C1118 ILE C1120 0 SHEET 2 CA 4 SER C1133 CYS C1138 -1 O GLN C1137 N GLY C1119 SHEET 3 CA 4 ARG C1149 ARG C1153 -1 O ILE C1150 N VAL C1134 SHEET 4 CA 4 GLN C1156 TRP C1157 -1 O GLN C1156 N ARG C1153 SHEET 1 CB 2 GLN C1143 GLU C1145 0 SHEET 2 CB 2 LYS C1162 LEU C1164 -1 O LYS C1162 N GLU C1145 SHEET 1 CC 2 CYS C1167 SER C1170 0 SHEET 2 CC 2 LYS C1188 SER C1191 -1 O LEU C1189 N ILE C1169 SHEET 1 CD 4 ILE C1179 LEU C1181 0 SHEET 2 CD 4 SER C1196 CYS C1201 -1 O VAL C1200 N ALA C1180 SHEET 3 CD 4 ARG C1215 TRP C1219 -1 O THR C1216 N VAL C1197 SHEET 4 CD 4 LYS C1222 LEU C1223 -1 O LYS C1222 N TRP C1219
SSBOND 1 CYS A 108 CYS A 165 1555 1555 2.05 SSBOND 2 CYS B 108 CYS B 165 1555 1555 2.04 SSBOND 3 CYS C 1109 CYS C 1152 1555 1555 2.03 SSBOND 4 CYS C 1138 CYS C 1163 1555 1555 2.03 SSBOND 5 CYS C 1167 CYS C 1218 1555 1555 2.06 SSBOND 6 CYS C 1201 CYS C 1228 1555 1555 2.04
CISPEP 1 ALA C 1129 PRO C 1130 0 -1.42 CISPEP 2 LYS C 1186 GLN C 1187 0 8.93
CRYST1 103.554 103.554 141.211 90.00 90.00 120.00 P 61 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009657 0.005575 0.000000 0.00000
SCALE2 0.000000 0.011151 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007082 0.00000
MTRIX1 1 0.836920 0.418010 0.353310 41.98795 1
MTRIX2 1 -0.180510 0.820210 -0.542830 19.24354 1
MTRIX3 1 -0.516700 0.390540 0.761910 -16.83389 1